Form D Explorer
Bonum Therapeutics, Inc. · CIK 1898714

Report a data issueCitable research briefCompare issuerPrivate research collection

Bonum Therapeutics, Inc.

CIK 1898714 · Corporation · Inc. DELAWARE · SEATTLE, Washington · Biotechnology
Filings
1
Original notices
1
Amendments
0
Activity
Apr 17, 2026
through Apr 17, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Apr 17, 2026

Reported offering amount
$32,301,381
Reported exemptions
Rule 506(b)
Reported amount sold
$26,907,396

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)